Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

The Football Show: Duff's man-...

00:39:27

The Football Show: Duff's man-management, Canham's FAI & Noel King to Dundalk!

OTB Football

00:39:27


The Football Pod members: Blue...

00:49:09

The Football Pod members: Blueprint for beating Donegal, Armagh expectations, can Kildare catch Louth?

OTB GAA

00:49:09


Pat Carty: 'I deleted Facebook...

00:08:46

Pat Carty: 'I deleted Facebook and Twitter, and I found it hard'

The Hard Shoulder Highlights

00:08:46


Should we tax fast fashion?

00:06:47

Should we tax fast fashion?

The Hard Shoulder Highlights

00:06:47